Skip to content

ITRAQ-Based Serum Proteomic Analysis of Tuina therapy for Neck pain: A randomized controlled study

ITRAQ-Based Serum Proteomic Analysis of Tuina therapy for Neck pain: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002354
Enrollment
Unknown
Registered
2019-05-23
Start date
2019-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Interventions

Sponsors

Hubei Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 28 Years

Inclusion criteria

Inclusion criteria: 1. The main complaint is neck pain stiffness or limited cervical activity and meets the diagnostic criteria; 2. Aged 18 to 28 years, gender is not limited; 3. The neck pain VAS score is 3-7; 4. Voluntary participation in the study and signing of the informed consent. Note: subjects with neck pain who meet all the above four criteria are allowed to be included in this study.

Exclusion criteria

Exclusion criteria: 1. A history of trauma such as cervical fracture and dislocation; 2. Skin damage on neck and shoulder; 3. Neck pain with numbness, dizziness, nausea, vomiting, blurred vision, palpitation symptoms; 4. Previous medical history of severe heart, liver, kidney, immune system, blood, digestive system, cancer, tumor, tuberculosis, etc.; 5. Severe mental disorder; 6. Pregnancy and lactation; 7. Are participating in other clinical trials that interfere with this study; 8. Oral analgesics within one week. Note: subjects who meet any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Neck Disability Index, NDI;Visual Analogue Scale/Score, VAS;

Secondary

MeasureTime frame
Self-rating depression scale, Zung(SDS);Living habits;Zung Self-Rating Anxiety Scale Zung(SAS);

Countries

China

Contacts

Public ContactJing Zhou

Hubei Province hospital of TCM

zhoujing@hbhtcm.com+86 138 7146 9953

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026